Work

Primed for toxicity: CD4+ T cells and immune checkpoint inhibitors

Year: 2022

Type: article

Source: Med

DOI: 10.1016/j.medj.2022.02.003

Authors: Douglas B. Johnson, Justin M. Balko

Institution: Vanderbilt University Medical Center

Language: Norwegian

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Bristol-Myers Squibb

OpenAlex ID: W4221097139

FWCI: 0.314

Cites: 8

Cited by: 3

Related to: 10